Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Connect Biopharma Holdings Ltd
CNTBCurrent price
1.09 USD
-0.0044 USD (-0.40%)
Last closed
1.08 USD
Company
www.connectbiopharm.com
ISIN
US2075231017
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
60 226 860 USD
Yield for 12 month
+5.41 %
1Y
3Y
5Y
10Y
15Y
CNTB
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California. Address: 12265 El Camino Real, San Diego, CA, United States, 92130
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+12 058 000 USD
Last Quarter
+12 058 000 USD
Current Year
-988 000 USD
Last Year
-1 030 634 USD
Current Quarter
+12 058 000 USD
Last Quarter
+12 058 000 USD
Key Figures CNTB
1 year
3 years
5 years
10 years
EBITDA
-24 951 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-12.13 %
PEG Ratio
–
Return On Equity TTM
-17.92 %
Wall Street Target Price
7.00 USD
Revenue TTM
24 116 000 USD
Book Value
2.00 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.39 USD
Diluted Eps TTM
-0.39 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-88.66 %
Dividend Analytics CNTB
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History CNTB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CNTB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
0.77
Enterprise Value Revenue
–
Price Sales TTM
2.50
Enterprise Value EBITDA
0.19
Price Book MRQ
0.55
Financials CNTB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CNTB
For 52 weeks
0.77 USD
2.66 USD
50 Day MA
1.15 USD
Shares Short Prior Month
61 794
200 Day MA
1.35 USD
Short Ratio
1.93
Shares Short
57 184
Short Percent
0.18 %
BeatStart